Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Symmetry Medical Gets 510K Clearance For FLASH PAK Evolution Valve - Quick Facts

RELATED NEWS
Trade SMA now with 
8/28/2012 8:35 AM ET

Symmetry Medical Inc. (SMA: Quote) said it received United States Food and Drug Administration or FDA 510K clearance for its FLASH PAK Evolution valve. The Evolution valve is the next generation valve for Symmetry's immediate use (flash) sterilization product, FLASH PAK, and is distributed exclusively through Symmetry Surgical. The company added that the patent pending stainless steel construction of the new valve is designed for ease of use and simplicity of care.

Chris Huntington, chief operating officer of Symmetry Surgical, said, "Making care and maintenance of our products easy is a key mission of Symmetry Surgical. The Evolution valve brings a new level of innovation to our market leading FLASH PAK; a product that clinicians have grown to depend on for over 20 years."

Click here to receive FREE breaking news email alerts for Symmetry Medical Inc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
China's manufacturing activity contracted at a faster pace in June, reducing the prospects of a promising economic recovery, preliminary results of a survey by Markit Economics and HSBC revealed Thursday. The flash manufacturing purchasing managers' index fell to 48.3 in June from 49.2 in May. The index is now at its lowest level in nine months. Bank of England Governor Mervyn King made a last but strong call for expanding stimulus for the British economy in his final Mansion House speech on Wednesday even as he left some "unfinished business" in the banking sector for the next chief Mark Carney to complete. King will step down by end-June after ten years at the helm. Carney will assume office from July 1. Red Hat Inc., the world's largest seller of Linux software, said Wednesday after the markets closed that its first quarter profit rose 8% from last year, as revenue increased 15% amid strong consumer demand. The company's quarterly earnings per share, excluding items, also came in above analysts' expectations as did its quarterly revenue.
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.